Hims & Hers Health Inc (NYSE:HIMS) has a beta value of 1.34 and has seen 3.8 million shares traded in the recent trading session. The company, currently valued at $6.75B, closed the recent trade at $30.90 per share which meant it gained $0.03 on the day or 0.10% during that session. The HIMS stock price is -13.33% off its 52-week high price of $35.02 and 72.46% above the 52-week low of $8.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 10.51 million shares traded. The 3-month trading volume is 16.30 million shares.
The consensus among analysts is that Hims & Hers Health Inc (HIMS) is Buy stock at the moment, with a recommendation rating of 2.25. 0 analysts rate the stock as a Sell, while 1 rate it as Overweight. 5 out of 13 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.21.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Sporting 0.10% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the HIMS stock price touched $30.90 or saw a rise of 3.65%. Year-to-date, Hims & Hers Health Inc shares have moved 27.80%, while the 5-day performance has seen it change 10.96%. Over the past 30 days, the shares of Hims & Hers Health Inc (NYSE:HIMS) have changed 11.96%. Short interest in the company has seen 52.12 million shares shorted with days to cover at 4.12.
Wall Street analysts have a consensus price target for the stock at $23, which means that the shares’ value could drop -34.35% from the levels at last check today. The projected low price target is $18.0 while the price target rests at a high of $38.0. In that case, then, we find that the latest price level in today’s session is -22.98% off the targeted high while a plunge would see the stock lose 41.75% from the levels at last check today.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Figures show that Hims & Hers Health Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 32.91% over the past 6 months, with this year growth rate of 600.00%, compared to 24.70% for the industry. Revenue growth from the last financial year stood is estimated to be 67.63%.
13 analysts offering their estimates for the company have set an average revenue estimate of 469.68M for the current quarter. 10 have an estimated revenue figure of 492.44M for the next ending quarter. Year-ago sales stood 246.62M and 278.17M respectively for this quarter and the next, and analysts expect sales will grow by 90.45% for the current quarter and 67.63% for the next.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
Insiders own 11.44% of the company shares, while shares held by institutions stand at 64.27% with a share float percentage of 72.57%. Investors are also buoyed by the number of investors in a company, with Hims & Hers Health Inc having a total of 446.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 16.47 million shares worth more than $332.55 million. As of 2024-06-30, VANGUARD GROUP INC held 7.7166% of shares outstanding.
The other major institutional holder is BLACKROCK INC., with the holding of over 14.57 million shares as of 2024-06-30. The firm’s total holdings are worth over $294.25 million and represent 6.8278% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund. As of Nov 30, 2024 , the former fund manager holds about 5.85% shares in the company for having 12.28 shares of worth $378.54 million while later fund manager owns 5.31 shares of worth $163.66 million as of Sep 30, 2024 , which makes it owner of about 2.53% of company’s outstanding stock.
